HOSPITAL ADMINISTRATIVE POLICY

Size: px
Start display at page:

Download "HOSPITAL ADMINISTRATIVE POLICY"

Transcription

1 HOSPITAL ADMINISTRATIVE POLICY INSTITUTIONAL REVIEW BOARD GOVERNANCE POLICY Document No.: Revision: Original Date: Effective Date: NUH-HAP-ROF Apr Apr-2013 : Description of Content/Change: : New Document Major Content Change Minor Content Change Non-content Change Deletions Only Any hardcopy, printed or photocopied, is considered an uncontrolled copy, unless it is the original, signed-off version. 1.0 Objectives 1.1 The Objective of this policy is to govern the function of the Institutional Review Board of NUH (herein after known as IRB ). 2.0 Scope 2.1 This policy applies to the Institutional Review Board of NUH regardless of the name it is given and whether it is in-house or out-sourced. 3.0 Definition 3.1 Institutional Review Board: An independent body constituted of medical, scientific, and non-scientific members, whose responsibility is to ensure the protection of the rights, safety, and well-being of human subjects involved in a research study by, among other things, reviewing, approving, and providing continuing review of research studies, of protocols and amendments, and of the methods and materials to be used in obtaining and documenting informed consent of the research subjects. 3.2 Serious Adverse Event: Adverse reaction to administered drug as defined by local laws and regulations e.g. Singapore Good Clinical Practice. 3.3 Human Research: Any research on human subjects that requires IRB approval as defined by local laws, regulations and guidelines. Print Date: Page 1 of 7

2 4.0 Reference 4.1 This IRB Policy references the Ministry of Health Institutional Review Board Operational Guide. 5.0 Policy 5.1 The functions of NUH Institutional Review Board (IRB) are (1) (a) (b) (c) To carry out review of any proposed human research on ethical grounds; thereafter, (i) To grant its approval for the human research to be conducted or; (ii) To communicate with Researchers and require modifications to be made to the research protocol before granting its approval; (iii) To disallow the conduct or continuation of the research protocol, with written justifications; or (iv) Grant exemption for the requirement for the research to be reviewed by IRB, if the risk is deemed to be minimal. To carry out a review of the progress of human research on ethical grounds at least annually. 5.2 Every proposed research protocol shall undergo one of the following 3 types of ethics review corresponding to its risk of harm to research subjects (2,8): (a) Full Review: All research protocol involving interventions that pose a more than minimal risk to research subjects shall be subjected to a full review. Minimal risk refers to the probability and magnitude of harm and discomfort anticipated in the research that are not greater, in and of themselves, than those ordinarily encountered in daily life or during the performance of routine physical or psychological examination or tests. Research projects with special ethics concern e.g. that involve the creation of human embryonic stem cell lines also require full ethics review. (b)expedited Review: Research protocol involving minimal or remote risk to research subjects may be reviewed via an expedited track by IRB, where appropriate. The Chairperson alone or at least one IRB members may make decisions on research protocol that qualify for expedited review. Decisions made by the members must be unanimous. Operational procedures on the expedited review of research protocol, e.g. authority of IRB Chairperson, delegation of tasks to IRB members and the method of reporting and ratification of decisions to the full board, should be clearly documented. Print Date: Page 2 of 7

3 (c)exempt Review: (i) Decision on endorsement of exempted status for exempt reviews may be made by the Chairman alone or at least one IRB member. (ii)researchers shall be required to submit all research protocols to the IRB for endorsement of their status of exemption. (iii)researchers who are aware that research protocols eligible for exempt review have a likelihood of harm to the research subject, should highlight the likelihood of harm to the IRB when submitting for review. 5.3 The following elements of review shall be considered when an IRB reviews a research protocol, where applicable (9): (a) Scientific design and conduct of the clinical study (b) Recruitment of research subjects (c) Care and protection of research subjects (d) Protection of research subject privacy and confidentiality (e) Informed consent process (f) Community/subject considerations (g) Conflict of interest issues (h) Reimbursement and compensation (i) Adequacy of a data and safety monitoring plan 5.4 IRB shall have formal meetings regularly to review and decide on the research protocols submitted to IRB (7). 5.5 IRB shall provide Researcher(s) with an initial outcome of its review of the proposed research protocol in a timely manner (10). 5.6 IRB shall perform regular continuing review, such as the evaluation of progress updates of research protocols, adverse event reports provided by Researchers, to ensure the continued validity of ethics approval of research protocols approved by them. (10, 11, 12, 15) This evaluation may include feedback/complaints received on the respective research protocol Continuing review shall be performed at least once per year for each project, until the termination of the project Final reports should be submitted to IRB within three months of completion of project The frequency and type of monitoring determined by an IRB shall reflect the degree of risk to the research subjects IRB shall require the Researcher to submit written summaries of the progress of the research to the IRB at least annually. Print Date: Page 3 of 7

4 5.6.6 All unexpected serious adverse events (SAEs) related to the research need to be reported immediately to the IRB Expected SAEs shall be submitted as regular summary reports as required by IRB Researchers shall be required by IRB to report all unexpected deaths arising from the research immediately to MOH, followed by detailed, written reports IRB shall require the Researcher to inform them and seek their written approval for any deviations from the terms of approval of the project before they can be implemented, except when they are necessary to mitigate immediate hazards to subjects, or when the changes involve only logistical or administrative aspects of the project, in which case, IRB shall be informed within seven (7) calendar days. 5.7 IRB shall clearly communicate the monitoring and reporting requirements to Researchers. IRB shall also maintain a dialogue, and provide feedback, on application standards with their constituent Researchers and NUH (3, 14). 5.8 IRB has rights to suspend and discontinue human research. (4,13) Where an IRB is satisfied that circumstances have arisen such that a human research project is not being, or cannot be, conducted in accordance with the approved protocol and that, as a result, the safety and well-being of the research subjects are not, or will not, be protected, the IRB shall withdraw its approval and inform the Researcher and NUH of such withdrawal. from the IRB shall remain withheld till such time when adequate, appropriate changes have been made to satisfy the IRB s requirements Any withdrawal of approval shall be accompanied by a statement, expressing the reasons for the IRB s action, and relayed promptly to the Researcher, appropriate institutional officials and the relevant regulatory authority Researchers shall not continue any research project whereby ethics approval has been withdrawn, and shall comply with conditions imposed by the IRB required for reapproval of the project In the case of premature suspension/termination of a research project by a Researcher or sponsor, the Researcher shall promptly inform the IRB of, and provide a detailed written explanation for, the suspension/termination. The IRB may require a summary of the results of the project that have been collected to be communicated to the IRB. 5.9 IRB s documentation and record keeping shall be kept in order.(6,7) All documentation, whether in paper or electronic form, shall be kept in accordance with existing legislation and requirements, as well as institutional standards. Print Date: Page 4 of 7

5 5.9.2 All documentation and communication of an IRB shall be dated, filed, and archived. The IRB shall also maintain and update information on its list of IRB Chair and members IRB shall maintain a record of all research protocols received, with dates and actions taken by the IRB for its continuing ethics review Clear operating procedures shall be established, documented and made widely and easily available for important processes In the review of a research protocol, the views of the IRB shall be documented in writing, clearly identifying the study, the documents reviewed, and the dates for the following: (a) ; (b) Modifications required prior to its approval; (c) Non-approval; (d) Withdrawal of any prior approval All communications in relation to the review of the research protocol, activities and other proceedings of the IRB, shall be fully documented in writing, including: (a) Documents reviewed by members, including correspondence with other parties, and whether the opinion of another IRB was considered; (b) Whether approval was by expedited review; (c) Minority views that were discussed; (d) Outcome of discussion; (e) Terms and conditions, if any, of approval of any project; (f) A record of all concerns and feedback received regarding the conduct of approved research protocols; (g) Action taken by the IRB to monitor the conduct of the research The procedure for accessing and retrieving documents of the IRB shall be clearly documented to safeguard against unauthorized access to the documents of the IRB IRB shall also keep a list of essential documents for an appropriate number of years in accordance with existing standards of the institution and regulatory requirements, following the discontinuation or completion of a study The duration of archiving shall be in accordance with applicable regulatory requirements. It shall be clearly established in the standard operating procedures of the IRB, with modifications made for each protocol in consideration of inputs from the researcher, if deemed necessary, and be proportionate to the risk, and likelihood of appearance, of adverse events which may take a longer time to surface Research protocols that went through full ethics review should be archived for 20 years. Research protocols that went through expedited ethics review should be archived for 10 years. Research protocols that went through exempted ethics review should be archived for 6 years. Print Date: Page 5 of 7

6 5.10 During ethics review of human research that involves more than one institution, Researchers shall identify to their respective IRBs, the designated lead IRB, if any, that is responsible for the primary ethics review. Researchers, NUH and IRB shall: (a) Coordinate the review of multi-centre research projects, and communicate any concerns that they may have, with other IRBs reviewing the research protocol; and (b) Determine how the conduct of multi-centre research should be supervised and define the respective roles of each institution/organization and its respective IRB IRB is to put in place procedures for managing conflicts of interest with respect to IRB members.(5) A member of an IRB shall declare to the board the nature and extent of all conflicts of interest or potential conflicts of interest in relation to a matter under consideration by the board, including those arising from (a) His familial or other relationship with a director, partner or employee of the research institution which appointed the institutional review board; (b) His familial or other relationship with any of the researchers involved in the conduct of the human biomedical research being reviewed by the board; (c) His connection or association with any body or person funding the human biomedical research being reviewed by the board Where the IRB is satisfied that the member (referred to in this section as a conflicted member ) is unable to carry out his duties properly and effectively because of any conflicts of interest or potential conflicts of interest referred to in subsection (1), the conflicted member (a) (b) Shall not take part in any deliberation or decision of the board with respect to that matter; and Shall be disregarded for the purpose of constituting a quorum of the board for such deliberation or decision Notwithstanding , a conflicted member may, with the permission of the IRB, provide such information as the IRB may require, but he shall not participate in its deliberation of a matter, and shall not vote on any decision with respect to that matter A disclosure under and the decision of the IRB in regard to the participation of the member in the deliberations and decisions of the IRB under and shall be recorded in the minutes of the meeting of the board For the purposes of this section, the fact that a member of an IRB is an employee of the NUH, the IRB shall not, by that reason alone, be regarded as a situation where his interest is in conflict with his duty as a member of the IRB. Print Date: Page 6 of 7

7 5.12 Every application to an IRB for the review of human research shall be made by Researchers responsible for the conduct and supervision of the human research (16), and shall include (a) (b) (c) A statement on whether the same or a materially similar research protocol has been submitted before to another IRB; The research institution under whose supervision and control the research would be; and Any other information or other matter which is material for the board s decision on whether to approve the human research. 6.0 Guidelines 6.1 This IRB Policy references the Ministry of Health IRB Operational Guide. 7.0 Annexes Number References Reference Document 1 Investigator Manual, Section Investigator Manual, Section 5 3 Investigator Manual, Section A02 DSRB Members Duties and Responsibilities A04 Conflict of Interest - DSRB Members and Independent Consultants B03 DSRB Communications B04 Document Management C03 Expedited Review C04 Initial Review Criteria for C06 Outcome of Review C05 Continuing Review C07 Study Closure D01 Handling Non-Compliance D04 DSRB Audits E04 Conflict of Interest - Investigators Conflict of interest declaration form NHG+Investigator+ Manual+-+1st+Editio DSRB SOPs version 14 Sept 2009.pdf 201-C03 Expedited Review - 05 Dec 11 (F 201-C04 Initial Review - Criteria for A 201-E04 Conflict of Interest - Investigato Annex+B+ -+COI+Declaration+F Print Date: Page 7 of 7

Operational Guidelines for Institutional Review Boards

Operational Guidelines for Institutional Review Boards Operational Guidelines for Institutional Review Boards TABLE OF CONTENTS 1 Introduction 1 2 Definition of Human Biomedical Research 1 3 Basic Ethical Principles 2 4 Objectives of Document 3 5 Responsibilities

More information

MEREDITH COLLEGE INSTITUTIONAL REVIEW BOARD GUIDELINES FOR THE PROTECTION OF HUMAN PARTICIPANTS IN RESEARCH

MEREDITH COLLEGE INSTITUTIONAL REVIEW BOARD GUIDELINES FOR THE PROTECTION OF HUMAN PARTICIPANTS IN RESEARCH MEREDITH COLLEGE INSTITUTIONAL REVIEW BOARD GUIDELINES FOR THE PROTECTION OF HUMAN PARTICIPANTS IN RESEARCH I. Introduction Recognizing its responsibility to provide measures to reasonably protect individuals

More information

Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research

Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research 1. Objective: The objective of this SOP is to contribute to the effective functioning

More information

RESEARCH INVOLVING HUMAN SUBJECTS

RESEARCH INVOLVING HUMAN SUBJECTS RESEARCH INVOLVING HUMAN SUBJECTS GUIDELINES FOR IRBS EXECUTIVE SUMMARY Principle 1. There is general agreement internationally that human biomedical research involving risk of harm to human subjects should

More information

Guidance on IRB Continuing Review of Research

Guidance on IRB Continuing Review of Research NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of

More information

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB) March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for

More information

12.0 Investigator Responsibilities

12.0 Investigator Responsibilities v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,

More information

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal

More information

Investigator Responsibilities

Investigator Responsibilities Investigator Responsibilities Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 010 Version number: 1 Effective date: 01 June 2010 Review due: May 2011

More information

SAN DIEGO CITY COLLEGE RESEARCH COMMITTEE INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS

SAN DIEGO CITY COLLEGE RESEARCH COMMITTEE INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS BACKGROUND SAN DIEGO CITY COLLEGE RESEARCH COMMITTEE INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS The first priority of the San Diego City College Research

More information

Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP.

Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP. Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection

More information

GOVERNANCE FRAMEWORK FOR HUMAN BIOMEDICAL RESEARCH

GOVERNANCE FRAMEWORK FOR HUMAN BIOMEDICAL RESEARCH GOVERNANCE FRAMEWORK FOR HUMAN BIOMEDICAL RESEARCH This document outlines the governance framework for human biomedical research (HBR), specifically the roles and responsibilities of parties which are

More information

SAN DIEGO COMMUNITY COLLEGE DISTRICT INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS

SAN DIEGO COMMUNITY COLLEGE DISTRICT INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS BACKGROUND SAN DIEGO COMMUNITY COLLEGE DISTRICT INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS The first priority of the SDCCD Institutional Review Board (IRB)

More information

Tip Sheet 11: Following the Guideline of the International Conference on Harmonization Good Clinical Practice (E6)

Tip Sheet 11: Following the Guideline of the International Conference on Harmonization Good Clinical Practice (E6) Tip Sheet 11: Following the Guideline of the International Conference on Harmonization Good Clinical Practice (E6) Related Accreditation Elements: I.1.D., I.1.F., I-2, I.7.B., II.2.E., II.2.F., II.4.A.,

More information

Section 5: Recordkeeping, Reporting, Non-Compliance, Unanticipated Problems, Adverse Events, Suspension, Termination

Section 5: Recordkeeping, Reporting, Non-Compliance, Unanticipated Problems, Adverse Events, Suspension, Termination Section 5: Recordkeeping, Reporting, Non-Compliance, Unanticipated Problems, Adverse Events, Suspension, Termination 5.1. Recordkeeping Policy In accordance with federal regulations (45 CFR 46.115 and

More information

GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE

GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE ICH E6 GCP: Consolidated Guideline: Investigator 1/7 Institutional Review Board Services ICH HARMONIZED TRIPARTITE GUIDELINE E6: GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE 4. INVESTIGATOR 4.1 Investigator's

More information

University of Oklahoma Office of Human Research Participant Protection SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES

University of Oklahoma Office of Human Research Participant Protection SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES 1. POLICY SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES The purpose of this policy is to outline the qualifications and responsibilities of the principal investigator and key personnel who

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,

More information

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 1. Introduction The St. Michael s Hospital (SMH) REB

More information

STANDARD OPERATING POLICY AND PROCEDURE

STANDARD OPERATING POLICY AND PROCEDURE STANDARD OPERATING POLICY AND PROCEDURE SUBJECT: Biospecimen Request and Release Policy Number: 500.0 Policy Date: 1/16/2009 Amendment Date: N/A Revision Date: 5-3-2010 I. INTRODUCTION AND PURPOSE The

More information

INTERIM SITE MONITORING PROCEDURE

INTERIM SITE MONITORING PROCEDURE INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.

More information

Principal Investigator and Sub Investigator Responsibilities

Principal Investigator and Sub Investigator Responsibilities Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal

More information

STANDARD OPERATING PROCEDURES

STANDARD OPERATING PROCEDURES Institutional Review Board STANDARD OPERATING PROCEDURES CONSTITUTING THE ETHICS REVIEW COMMITTEE FOR BIOMEDICAL RESEARCH SOP Number 001 Version No. 1.0, September 2012 SOP Status Final Effective by :

More information

2U, INC. CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS PURPOSE AND POLICY

2U, INC. CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS PURPOSE AND POLICY 2U, INC. CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS PURPOSE AND POLICY The purpose of the Compensation Committee (the Committee ) of the Board of Directors (the Board ) of 2U, INC.,

More information

Human Research Ethics Committee. Standard Operating Procedures

Human Research Ethics Committee. Standard Operating Procedures Human Research Ethics Committee Standard Operating Procedures Version: 19 July 2012 Contents 1. Appointment of Members... 1 2. Orientation of New Members... 3 3. Preparation of Agenda... 4 4. Conduct of

More information

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.

More information

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators

More information

Adventist HealthCare, Inc.

Adventist HealthCare, Inc. IRB POLICY ON HUMAN RESEARCH PROTECTION (HRP) AND GOOD CLINICAL PRACTICE (GCP) TRAINING Collaborative Institutional Training Initiative (CITI) Requirements at Adventist Healthcare, Inc. I. Required Human

More information

9.0 Protocol Violations, Deviations, and Exceptions. 9.1 Definitions

9.0 Protocol Violations, Deviations, and Exceptions. 9.1 Definitions 9.0 Protocol Violations, Deviations, and Exceptions 9.1 Definitions Protocol deviation(s): means a minor or administrative departure from the IRBapproved protocol procedures (e.g., the protocol, informed

More information

CNE Disclosures. To change this title, go to Notes Master

CNE Disclosures. To change this title, go to Notes Master CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion

More information

RESEARCH INVOLVING HUMAN SUBJECTS

RESEARCH INVOLVING HUMAN SUBJECTS RESEARCH INVOLVING HUMAN SUBJECTS GUIDELINES FOR IRBS PART A: INTRODUCTION AND CURRENT FRAMEWORK SECTION I: INTRODUCTION 1. Introduction About these Guidelines 1.1. The Bioethics Advisory Committee (BAC)

More information

BJC HealthCare CORPORATE COMPLIANCE POLICY. APPLIES TO: BJC HealthCare and all BJC Members and Affiliates

BJC HealthCare CORPORATE COMPLIANCE POLICY. APPLIES TO: BJC HealthCare and all BJC Members and Affiliates Page 1 of 11 BJC HealthCare CORPORATE COMPLIANCE POLICY APPLIES TO: BJC HealthCare and all BJC Members and Affiliates TITLE: BJC HealthCare Financial Conflict of Interest in Research Policy NUMBER: 9.1

More information

Research Institute Administration

Research Institute Administration PROTOCOL DEVIATIONS 229 1 of 7 PURPOSE The purpose of this policy is to define protocol deviations and the subsequent actions required by the Principal Investigator (PI) once a protocol deviation occurs

More information

Management of Protocol Deviations, Violations and Urgent Safety Measures

Management of Protocol Deviations, Violations and Urgent Safety Measures This is a controlled document. The master document is posted on the JRO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

IOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others

IOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others IOWA STATE UNIVERSITY Institutional Review Board Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others Introduction This policy details the Institutional Review Board

More information

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how

More information

FMC TECHNOLOGIES, INC. CHARTER OF THE NOMINATING AND GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS

FMC TECHNOLOGIES, INC. CHARTER OF THE NOMINATING AND GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS FMC TECHNOLOGIES, INC. CHARTER OF THE NOMINATING AND GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS Purpose of the Nominating and Governance Committee The Nominating and Governance Committee is appointed

More information

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University IRB Submissions and Human Subjects Research Compliance Offi f H R hp t ti Office of Human Research Protection Georgia Health Sciences University Objectives Identify the steps required to submit a protocol

More information

Outsourcing Publication Date: September 2013 OUTSOURCING. 1. Legislation Guidance Exercising due skill, care and diligence...

Outsourcing Publication Date: September 2013 OUTSOURCING. 1. Legislation Guidance Exercising due skill, care and diligence... OUTSOURCING Contents 1. Legislation... 2 2. Guidance... 7 2.1 Exercising due skill, care and diligence... 7 2.2 Outsourcing agreement... 7 2.3 Outsourcing policy... 8 2.4 Business continuity plan... 9

More information

Document Title: Research Database Application (ReDA)

Document Title: Research Database Application (ReDA) Document Title: Research Database Application (ReDA) Document Number: SOP035 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

LEBANESE MINISTRY OF HEALTH DIRECTIVE

LEBANESE MINISTRY OF HEALTH DIRECTIVE LEBANESE MINISTRY OF HEALTH DIRECTIVE LAYING DOWN DETAILED GUIDELINES FOR SPONSORS OF CLINICAL TRIALS March 2012 Field of Application General Considerations Trial s submission Validity of the F-MRI opinion

More information

FDA Audit Guidelines. University of Miami. Office of the Vice Provost for Research

FDA Audit Guidelines. University of Miami. Office of the Vice Provost for Research FDA Audit Guidelines University of Miami Office of the Vice Provost for Research FDA Audit Guidelines Contents INTRODUCTION 3 VICE PROVOST FOR RESEARCH ROLE IN FDA AUDITS 3 PRE-AUDIT REVIEW 3 INSPECTION

More information

AAHRPP Standards. Investigator Responsibilities for Research Involving Human Subjects

AAHRPP Standards. Investigator Responsibilities for Research Involving Human Subjects AAHRPP Standards Investigator Responsibilities for Research Involving Human Subjects Regulatory Landscape 2 AAHRPP OHRP FDA Pennington Louisiana Laws The Association for the Accreditation of Human Research

More information

Document Title: Trust Approval and Research Governance

Document Title: Trust Approval and Research Governance Document Title: Trust Approval and Research Governance Document Number: SOP034 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

Introduction to Institutional Review Boards (IRBs) Holly Taylor, MPH, PhD Johns Hopkins University

Introduction to Institutional Review Boards (IRBs) Holly Taylor, MPH, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Bellarmine University Institutional Review Board (IRB) Handbook Policies and Procedures for the Review of Research Involving Human Subjects

Bellarmine University Institutional Review Board (IRB) Handbook Policies and Procedures for the Review of Research Involving Human Subjects Bellarmine University Institutional Review Board (IRB) Handbook Policies and Procedures for the Review of Research Involving Human Subjects Last Reviewed and Approved 5/19/14 1. Purpose & Mission Human

More information

The Institutional Review Board (IRB) Manual

The Institutional Review Board (IRB) Manual The Institutional Review Board (IRB) Manual Institutional Review Board (IRB) Conflict of Interest Policy Purpose and Scope This Policy applies to all investigators at Boston Children s Hospital ( Children

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) The Netherlands

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) The Netherlands The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe The Netherlands Question 1: What laws or regulations apply to an application for conducting a clinical trial in

More information

Quality Control for Firms. Audits and Reviews of Historical Financial Information, and Other Assurance and Related Services Engagements

Quality Control for Firms. Audits and Reviews of Historical Financial Information, and Other Assurance and Related Services Engagements * Issued October 2004 Effective as of 15 June 2005* Hong Kong Standard on Quality Control 1 Quality Control for Firms That Perform Audits and Reviews of Historical Financial Information, and Other Assurance

More information

and Regulatory Aspects

and Regulatory Aspects Good Clinical Practice and Regulatory Aspects Nora Espiritu MD, MPh, PhD (c) Former Executive Director of Research and Technology Transfer. Peruvian National Institute t of Health. Member of the Ethics

More information

STANDARDS OF PRACTICE (2013)

STANDARDS OF PRACTICE (2013) STANDARDS OF PRACTICE (2013) COLLEGE OF ALBERTA PSYCHOLOGISTS STANDARDS OF PRACTICE (2013) 1. INTRODUCTION The Health Professions Act (HPA) authorizes and requires the College of Alberta Psychologists

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I STUDY PROTOCOL CHAPTER 14 REVISED: OCTOBER 2015 THE STUDY PROTOCOL The study protocol is a written document detailing how a clinical trial is conducted. The elements of a protocol include: 1. Trial design and organization; 2. Study objectives; 3. Background

More information

COUNCIL PROCEDURE RULES

COUNCIL PROCEDURE RULES COUNCIL PROCEDURE RULES 1. Introduction 2. Annual Meetings of Full Council 3. Ordinary Meetings of Full Council 4. Extraordinary Meetings of Full Council 5. Special Meetings 6. Time and Location of Meetings

More information

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI Ethical Principles for Medical Research Involving Human Subjects

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI Ethical Principles for Medical Research Involving Human Subjects WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI Ethical Principles for Medical Research Involving Human Subjects Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by

More information

IRB Process & Medical Devices. Sandra Rogers IRB Pacific University

IRB Process & Medical Devices. Sandra Rogers IRB Pacific University + IRB Process & Medical Devices Sandra Rogers IRB Pacific University + IRB Review of Research: Criteria n Informed Consent (Respect for Persons) n Will be sought prospectively n Includes required elements

More information

COMPENSATION COMMITTEE CHARTER

COMPENSATION COMMITTEE CHARTER COMPENSATION COMMITTEE CHARTER I. STATEMENT OF PURPOSE: The Compensation Committee (the Committee ) is established by the Board of Directors (the Board ) of Stonegate Bank (the Bank ) and is responsible

More information

TASMC INSTITUTIONAL REVIEW BOARD

TASMC INSTITUTIONAL REVIEW BOARD (Translation from Hebrew) Page 1 of 19 1 DEFINITIONS 1.1 The institutional committee supervising medical studies and experiments involving human subjects at the Tel-Aviv Sourasky Medical Center (TASMC)

More information

DATA RETENTION POLICY

DATA RETENTION POLICY DATA RETENTION POLICY Contents 1. Key Principles... 3 2. Introduction to the Policy and Guidelines... 3 3. Policy and Guidelines... 4 4. Scottish Ministers Requirements... 5 5. Access to information...

More information

Human Subjects Research (HSR) Series

Human Subjects Research (HSR) Series Human Subjects Research (HSR) Series CITI Program s HSR series consists of modules from two basic tracks, Biomedical (Biomed) and Social- Behavioral- Educational (SBE), and a set of Additional Modules

More information

BOARD CHARTER TABLE OF CONTENTS 1. PURPOSE 2 2. RESPONSIBILITIES OF THE GRAINCORP BOARD 2 3. BOARD STRUCTURE AND APPOINTMENT 3

BOARD CHARTER TABLE OF CONTENTS 1. PURPOSE 2 2. RESPONSIBILITIES OF THE GRAINCORP BOARD 2 3. BOARD STRUCTURE AND APPOINTMENT 3 TABLE OF CONTENTS 1. PURPOSE 2 2. RESPONSIBILITIES OF THE GRAINCORP BOARD 2 3. BOARD STRUCTURE AND APPOINTMENT 3 4. BOARD S RIGHTS AND RESPONSIBILITIES 4 5. CHAIRMAN 5 6. MANAGING DIRECTOR/CEO 6 7. COMPANY

More information

To IRB, or Not to IRB? That Is the Question!

To IRB, or Not to IRB? That Is the Question! To IRB, or Not to IRB? That Is the Question! A presentation by Mary Sapp, Ph.D. Assistant Vice President, Planning & Institutional Research University of Miami and Thomas K. Martin, Ph.D. Associate Vice

More information

[Section 7] CLINICAL TRIALS. A. Clinical Equipoise. B. Phases of Pharmaceutical Research [ 7.1 ]

[Section 7] CLINICAL TRIALS. A. Clinical Equipoise. B. Phases of Pharmaceutical Research [ 7.1 ] [Section 7] CLINICAL TRIALS Clinical trials are most frequently undertaken in biomedical or health research, although other clinically related disciplines, such as psychology, also conduct research that

More information

R&D Administration Manager. Research and Development. Research and Development

R&D Administration Manager. Research and Development. Research and Development Document Title: Document Number: Patient Recruitment SOP031 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager,

More information

INVESTIGATOR HANDBOOK

INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK Liberty IRB, Inc. 1450 S. Woodland Blvd., Suite 300A Deland, Florida 32720 Phone (386) 279-4318 Fax: (386)868-4563 Website: www.libertyirb.com Business hours: Monday Friday, 8:00am

More information

This policy applies to all clinical research conducted at Beaumont Health System.

This policy applies to all clinical research conducted at Beaumont Health System. CLINICAL RESEARCH QUALITY AND PROCESS IMPROVEMENT PROGRAM 113 1 of 6 PURPOSE Prior The purpose of this policy is to provide an overview of the Clinical Research Quality and Process Improvement Program

More information

OPERATING PROCEDURES

OPERATING PROCEDURES OPERATING PROCEDURES CATEGORY: RESEARCH AFFAIRS CODE: H-27A APPROVED: 8/17/2010 SUBJECT: PROCEDURES FOR CONDUCT OF CONVENED IMPLEMENTED: 11/2010 REPLACES: PAGE: 1 of 6 Please note: Definitions are found

More information

Appendix 1. This appendix is a proposed new module of the DFSA Rulebook. Therefore, the text is not underlined as it is all new text.

Appendix 1. This appendix is a proposed new module of the DFSA Rulebook. Therefore, the text is not underlined as it is all new text. Appendix 1 This appendix is a proposed new module of the DFSA Rulebook. Therefore, the text is not underlined as it is all new text. The DFSA Rulebook Auditor Module (AUD) PART 1 INTRODUCTION 1 APPLICATION

More information

2.1.4 Having regard to its role, the Board will direct and overview the business and affairs of the Company, including in particular:

2.1.4 Having regard to its role, the Board will direct and overview the business and affairs of the Company, including in particular: CCHL BOARD CHARTER 1. Company Mission Statement To support the Council s vision for the city by investing in, and promoting the establishment of, key infrastructure assets in a commercially viable manner

More information

THOMSON REUTERS CORPORATE GOVERNANCE COMMITTEE CHARTER

THOMSON REUTERS CORPORATE GOVERNANCE COMMITTEE CHARTER THOMSON REUTERS CORPORATE GOVERNANCE COMMITTEE CHARTER ADOPTED EFFECTIVE MARCH 3, 2016 TABLE OF CONTENTS 1. PURPOSE... 1 2. MEMBERS... 1 3. RESPONSIBILITIES... 1 4. REPORTING... 5 5. REVIEW... 6 6. ASSESSMENT...

More information

Data Management DM STANDARD OPERATING PROCEDURE FOR Data Management

Data Management DM STANDARD OPERATING PROCEDURE FOR Data Management Data Management DM 401.00 STANDARD OPERATING PROCEDURE FOR Data Management Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell, MD, FACP

More information

CATALENT, INC. COMPENSATION COMMITTEE CHARTER

CATALENT, INC. COMPENSATION COMMITTEE CHARTER CATALENT, INC. COMPENSATION COMMITTEE CHARTER I. PURPOSE The Compensation Committee (the Committee ) shall provide assistance to the Board of Directors (the Board of Directors ) of Catalent, Inc. (the

More information

EP ENERGY CORPORATION AUDIT COMMITTEE CHARTER. December 14, 2016

EP ENERGY CORPORATION AUDIT COMMITTEE CHARTER. December 14, 2016 EP ENERGY CORPORATION AUDIT COMMITTEE CHARTER December 14, 2016 Chapter 1 Purpose The primary purpose of the Audit Committee (the Committee ) is to assist the Board of Directors (the Board ) of EP Energy

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy

Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors

More information

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s Author: Lisa Austin, Research Manager Purpose and Objective: To identify and standardise

More information

The Prince Charles Hospital Human Research Ethics Committee (EC00168) Terms of Reference. Metro North Hospital and Health Service

The Prince Charles Hospital Human Research Ethics Committee (EC00168) Terms of Reference. Metro North Hospital and Health Service The Prince Charles Hospital Human Research Ethics Committee (EC00168) Terms of Reference Metro North Hospital and Health Service Page 1 of 3 Contents... Error! Bookmark not defined. Introduction... 3 Preamble...

More information

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting M-306.00 SOP for Adverse Event Reporting Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature

More information

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD EMERGENCY MEDICINE RESEARCH EXEMPTION FROM INFORMED CONSENT REQUIREMENTS

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD EMERGENCY MEDICINE RESEARCH EXEMPTION FROM INFORMED CONSENT REQUIREMENTS UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD EMERGENCY MEDICINE RESEARCH EXEMPTION FROM INFORMED CONSENT REQUIREMENTS I. PURPOSE This document outlines the procedures for University

More information

Guidance for IRBs, Clinical Investigators, and Sponsors

Guidance for IRBs, Clinical Investigators, and Sponsors Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval U.S. Department of Health and Human Services Food and Drug Administration Center for

More information

Student Classroom Projects Involving Human Subjects (Guidance for Faculty)

Student Classroom Projects Involving Human Subjects (Guidance for Faculty) University of New England Institutional Review Board (IRB) Student Classroom Projects Involving Human Subjects (Guidance for Faculty) The University of New England (UNE) supports a wide range of both undergraduate

More information

PDC Energy, Inc. Corporate Governance Guidelines

PDC Energy, Inc. Corporate Governance Guidelines PDC Energy, Inc. Corporate Governance Guidelines As Amended June 4, 2015 The Board of Directors (the "Board") of PDC Energy, Inc. ( PDC or the Company ) has adopted these guidelines to promote the effective

More information

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM DoD/DON-funded Research Policy In 2006, the Department of the Navy (DON) enhanced its human subject protection requirements, including

More information

Ochsner Institutional Review Board (IRB) Written Procedures

Ochsner Institutional Review Board (IRB) Written Procedures Ochsner Institutional Review Board (IRB) Written Procedures Date of Revision: September 16, 2011 (click here for Revision History) Note: When possible, references and appendix material are hyperlinked

More information

Fixed Income And Asset Allocation Funds Governance And Nominating Committee Charter

Fixed Income And Asset Allocation Funds Governance And Nominating Committee Charter Fixed Income And Asset Allocation Funds Governance And Nominating Committee Charter I. Background The investment companies managed by Fidelity Management & Research Company or its affiliates (collectively,

More information

Miami University: Human Subjects Research General Research Application Guidance

Miami University: Human Subjects Research General Research Application Guidance Miami University: Human Subjects Research General Research Application Guidance Use the accompanying Word template for completing the research description. You must provide sufficient information regarding

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark Question 1: What laws or regulations apply to an application for conducting a clinical

More information

INSTRUCTIONS TO RESEARCHERS INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS

INSTRUCTIONS TO RESEARCHERS INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS INSTRUCTIONS TO RESEARCHERS INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS The Federal Requirement. As of 2001 Duquesne University maintains a relationship with federal research and funding agencies known as

More information

What is Covered under the Privacy Rule? Protected Health Information (PHI)

What is Covered under the Privacy Rule? Protected Health Information (PHI) HIPAA & RESEARCH What is Covered under the Privacy Rule? Protected Health Information (PHI) Health information + Identifier = PHI Transmitted or maintained in any form (paper, electronic, forms, web-based,

More information

DEVON ENERGY CORPORATION COMPENSATION COMMITTEE CHARTER

DEVON ENERGY CORPORATION COMPENSATION COMMITTEE CHARTER Page 1 of 5 DEVON ENERGY CORPORATION COMPENSATION COMMITTEE CHARTER A. PURPOSE The purpose of the Compensation Committee (the Committee ) of the Board of Directors (the Board ) of Devon Energy Corporation

More information

Measures. SOP Number: UoA-NHSG-SOP-045 Version No: 1

Measures. SOP Number: UoA-NHSG-SOP-045 Version No: 1 Standard Operating Procedure: Management of Deviations, Breaches and Urgent Safety SOP Number: UoA-NHSG-SOP-045 Version No: 1 Author: Date: 27 th March 2015 (Patricia Burns, Research Governance Manager,

More information

STANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

STANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

More information

Public Policy Statement: Clinical Trial Ethics

Public Policy Statement: Clinical Trial Ethics Public Policy Statement: Clinical Trial Ethics Purpose As a global healthcare company, Merck's role is first and foremost to discover, develop and provide innovative products and services that save and

More information

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

Data Management Unit Research Institute for Health Sciences, Chiang Mai University Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data

More information

Paris, 15 June 2013 Response to a public consultation

Paris, 15 June 2013 Response to a public consultation Paris, 15 June 2013 Response to a public consultation Revision of the World Medical Association Helsinki Declaration: - transparency of clinical trial results must be enhanced (articles 23, 24 & 26) -

More information

Instructions for Form: Application for Claim of Exemption

Instructions for Form: Application for Claim of Exemption Instructions for Form: Application for Claim of Exemption In order to decide whether your activity involves research that may be reviewed and approved at the exempt level, review the following information.

More information

Document Title: Project Management of Papworth Sponsored Studies

Document Title: Project Management of Papworth Sponsored Studies Document Title: Project Management of Papworth Sponsored Studies Document Number: SOP009 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G

More information

Wake Forest School of Medicine. Human Research Protection Program and Institutional Review Board. Polices and Procedures

Wake Forest School of Medicine. Human Research Protection Program and Institutional Review Board. Polices and Procedures Wake Forest School of Medicine Human Research Protection Program and Institutional Review Board Polices and Procedures Contents 1.0 Ethical and Regulatory Mandates for the Protection of Human Research

More information

Essentials of RESEARCH GOVERNANCE

Essentials of RESEARCH GOVERNANCE Promoting Good Practice in Research Essentials of RESEARCH GOVERNANCE Information for Researchers, Students and Support Staff involved in Health & Social Care Research 2005 Reproduced with the permission

More information

Audit Committee Charter

Audit Committee Charter Audit Committee Charter Role The Audit Committee of the Board of Directors assists the Board of Directors in fulfilling its responsibility for oversight of the quality and integrity of the accounting,

More information